With OK From FDA, UC San Diego Researchers Prepare to Launch Novel Phage Study
FDA approves first U.S. clinical trial of an intravenously administered bacteriophage-based therapy to treat resistant bacterial infections.
FDA approves first U.S. clinical trial of an intravenously administered bacteriophage-based therapy to treat resistant bacterial infections.
Using CRISPR, researchers developed a way to suppress insects, including those that ravage crops and transmit deadly diseases. The technology alters genes for sex determination and fertility. When eggs are introduced, only sterile males emerge, resulting in a low-cost method of controlling pests.
UC San Diego researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Some dermal fibroblasts can convert into fat cells that reside under the dermis, giving skin a youthful look and producing peptides that fight infections. University of California San Diego School of Medicine researchers and colleagues show how this happens and what causes it to stop as people age.
Engineers have developed a neuroinspired hardware-software co-design approach that could make neural network training more energy-efficient and faster. Their work could one day make it possible to train neural networks on low-power devices such as smartphones, laptops and embedded devices.
Moderate to severe loneliness can persist across adult lifespans, but UC San Diego School of Medicine researchers found it is particularly acute in three age periods: late-20s, mid-50s and late-80s. Wisdom proved a protective factor.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.